Karen holds a PhD degree in Cellular and Molecular Biology from the University of Nice-Sophia Antipolis (France). She completed a 5-year post-doctoral training in the Department of Human Genetics at McGill University. Her research led to the identification of new tumor suppressor gene candidates and the generation of a new genetically modified ovarian cancer cell line model, with high potential to develop biomarkers for clinical application. Karen then worked within different groups at McGill University and the University of Montreal as a researcher and further developed biobanking and clinical sample profiling strategies, and participated in developing a multiplex blood-based assay for breast cancer detection.
Karen’s role as the Head of the Molecular Laboratory at Exactis is to implement new technologies and develop methods for tissue and blood sample processing for translational research projects. Karen also manages cytogenetics analyses using high-density SNP arrays and coordinates the integration of analyses that are carried out across multiple omic platforms, with the objectives to identify biomarkers and gene expression signatures to support the development of personalized medicine.